Multispectral polarimetric sensor for glucose monitoring utilizing a digital closed-loop control system /
5.35mg/dl for the 820nm wavelength. The system was
| Main Author: | |
|---|---|
| Format: | Thesis eBook |
| Language: | English |
| Published: |
[Place of publication not identified] :
[publisher not identified] ;
1998.
|
| Subjects: | |
| Online Access: | Link to OAKTrust copy |
| Summary: | 5.35mg/dl for the 820nm wavelength. The system was accurate blood analysis. Conventionally, blood is also able to extract glucose information to within an an optically choral sample such as glucose. A multi- analyzed by withdrawing a sample from the body of the and 7.61mg/dl for the 820nm wavelength for the and a fast feedback control system implemented in and other hormonal or metabolic imbalances, requires approach to glucose potential in this technique artifact studies indicated a clear trend of the two average standard deviation of 24.41mg/dl from a being researched to determine glucose levels in the body non-invasively. Polarized light experiences a change in its plane of rotation that is proportional concentrations in the blood. The purpose of this dual conventional methods is the invasive nature of the could be used to allow for glucose measurements in the designed and implemented. The potential site for in- deviation of 9.57mg/d1 for the 67013m wavelength and discomfort. The polarimetric approach is currently glucose. Glucose was predicted to within a standard hyperglycemic ranges of 0-600mg/dl of glucose doped Labview. Overall, the results are satisfactory and monitoring, namely, motion artifacts and the presence of other optically active substances at the test site. other choral substance used in this study. Motion overcoming two important problems with in-vivo glucose predictions in the hypoglycemic range of 0-100mg/dl of presence of motion artifacts. The novelty of the sensing. sensitivity. It predicted glucose to within an average show considerable being developed as an important solution of albumin and glucose, albumin being the standard deviation of 9.88mg/d1 for 670nm wavelength subject. One of the major disadvantages of system was its simultaneous dual wavelength approach tests that raise the risk of patient infection and The device was tested in-vitro for accuracy and to the concentration of the sample when passed through Treatment of many medical disorders, such as diabetes hics. vivo measurements is the aqueous humor of the eye, water. Improved results were obtained for glucose wavelength device is to provide the means for wavelength, multi-beam polarimetric device has been wavelengths in tracking each other, which potentially which shows glucose concentrations proportional to the |
|---|---|
| Item Description: | "Major subject: Biomedical Engineering". Vita. |
| Physical Description: | xi, 140 leaves : illustrations ; 28 cm. Also available online. |
| Bibliography: | Includes bibliographical references (leaves ). |